NM_000243.3:c.2177T>C

Variant summary

Our verdict is Pathogenic. The variant received 10 ACMG points: 12P and 2B. PS3PP5_Very_StrongBP4BS2_Supporting

The NM_000243.3(MEFV):​c.2177T>C​(p.Val726Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00131 in 1,614,072 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000629038: Experimental studies have shown that this missense change affects MEFV function (PMID:21600797)." and additional evidence is available in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V726I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0014 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 23 hom. )

Consequence

MEFV
NM_000243.3 missense

Scores

1
17

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:53O:2

Conservation

PhyloP100: -0.165

Publications

583 publications found
Variant links:
Genes affected
MEFV (HGNC:6998): (MEFV innate immunity regulator, pyrin) This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008]
MEFV Gene-Disease associations (from GenCC):
  • autosomal recessive familial Mediterranean fever
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • familial Mediterranean fever
    Inheritance: AR, SD, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Myriad Women’s Health, ClinGen, Orphanet
  • familial Mediterranean fever, autosomal dominant
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 10 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000629038: Experimental studies have shown that this missense change affects MEFV function (PMID: 21600797).; SCV000711424: "In vitro functional studies of the protein domain containing p.Val726Ala variant report an impact to protein binding." PMID:21600797; SCV001142454: Functional studies demonstrate that p.Val726Ala has decreased protein binding activity(PMID: 16785446).; SCV001469021: There is evidence that p.Val726Ala leads to decreased binding of the B30.2 domain of human pyrin to caspase-13 in vitro.; SCV005398586: "This variant has moderate functional evidence supporting abnormal protein function. In transfected cells, the mutant protein had decreased binding to caspase-1 (PMID: 16785446). This is consistent with the functional study using knock-in mice which showed gain of caspase-1 activation (PMID: 21600797)."; SCV000279062: Multiple published functional and FMF-knock-in mice studies demonstrate that this variant decreases protein binding activity (Chae et al., 2006) and shows decreased binding of PKN1 and 14-3-3 protein to murine pyrin in vivo, leading to constitutive activation of the pyrin inflammosome (Park YH et al., 2016); homozygosity for this MEFV variant in knock-in mice produced the most severe inflammation from all tested MEFV variants (Park YH et al., 2016).; SCV002318773: Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product (PMID: 21600797).; SCV005366093: "In vivo and in vitro experimental studies suggest this variant impacts protein function (Chae et al. 2011. PubMed ID: 21600797; Honda et al. 2021. PubMed ID: 33733382)."
PP5
Variant 16-3243310-A-G is Pathogenic according to our data. Variant chr16-3243310-A-G is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 2540.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.09626025). . Strength limited to SUPPORTING due to the PP5.
BS2
High Homozygotes in GnomAd4 at 3 AR,SD,AD geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000243.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MEFV
NM_000243.3
MANE Select
c.2177T>Cp.Val726Ala
missense
Exon 10 of 10NP_000234.1O15553-2
MEFV
NM_001198536.2
c.*381T>C
3_prime_UTR
Exon 9 of 9NP_001185465.2O15553-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MEFV
ENST00000219596.6
TSL:1 MANE Select
c.2177T>Cp.Val726Ala
missense
Exon 10 of 10ENSP00000219596.1O15553-2
MEFV
ENST00000541159.5
TSL:1
c.*381T>C
3_prime_UTR
Exon 9 of 9ENSP00000438711.1O15553-3
MEFV
ENST00000539145.5
TSL:1
n.*810T>C
non_coding_transcript_exon
Exon 7 of 7ENSP00000444471.1D2DTW1

Frequencies

GnomAD3 genomes
AF:
0.00144
AC:
219
AN:
152066
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000459
Gnomad ASJ
AF:
0.0421
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000721
Gnomad OTH
AF:
0.00336
GnomAD2 exomes
AF:
0.00217
AC:
545
AN:
251486
AF XY:
0.00190
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000231
Gnomad ASJ exome
AF:
0.0398
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000932
Gnomad OTH exome
AF:
0.00440
GnomAD4 exome
AF:
0.00130
AC:
1896
AN:
1461888
Hom.:
23
Cov.:
32
AF XY:
0.00132
AC XY:
963
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.0000896
AC:
3
AN:
33480
American (AMR)
AF:
0.000291
AC:
13
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0388
AC:
1013
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000128
AC:
11
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.0125
AC:
72
AN:
5768
European-Non Finnish (NFE)
AF:
0.000469
AC:
521
AN:
1112012
Other (OTH)
AF:
0.00435
AC:
263
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
132
265
397
530
662
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00144
AC:
219
AN:
152184
Hom.:
3
Cov.:
32
AF XY:
0.00144
AC XY:
107
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41528
American (AMR)
AF:
0.000458
AC:
7
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0421
AC:
146
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000721
AC:
49
AN:
68000
Other (OTH)
AF:
0.00380
AC:
8
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
12
24
37
49
61
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00201
Hom.:
16
Bravo
AF:
0.00154
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.00267
AC:
23
ExAC
AF:
0.00185
AC:
224
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00229
EpiControl
AF:
0.00160

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
24
-
-
Familial Mediterranean fever (25)
14
-
-
not provided (14)
6
-
-
Familial Mediterranean fever, autosomal dominant (6)
3
-
-
Familial Mediterranean fever;C0085077:Acute febrile neutrophilic dermatosis;C1851347:Familial Mediterranean fever, autosomal dominant (3)
2
-
-
Familial Mediterranean fever;C1851347:Familial Mediterranean fever, autosomal dominant (3)
2
-
-
MEFV-related disorder (2)
1
-
-
Autoinflammatory syndrome (1)
1
-
-
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
0.17
DANN
Benign
0.24
DEOGEN2
Benign
0.29
T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0041
N
LIST_S2
Benign
0.48
T
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.096
T
MetaSVM
Benign
-0.85
T
MutationAssessor
Benign
-2.2
N
PhyloP100
-0.17
PrimateAI
Benign
0.24
T
PROVEAN
Benign
1.9
N
REVEL
Uncertain
0.35
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0010
B
Vest4
0.26
MVP
0.53
MPC
0.14
ClinPred
0.023
T
GERP RS
-0.52
Varity_R
0.089
gMVP
0.13
Mutation Taster
=45/55
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28940579; hg19: chr16-3293310; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.